Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model
- PMID: 3302173
Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model
Abstract
Eight freshly excised pig hearts were hemoperfused by baboons in vivo. Cardiac function ceased in six hearts after a mean period of 90 minutes of perfusion (range 30 to 190 minutes). Two hearts continued functioning for the 4-hour study period. On microscopic examination, seven hearts, including one that continued beating, showed histopathologic features of hyperacute rejection. IgG, IgM, and C3 were strongly present on the myocardium in all cases. Hemoperfusion was associated with significant increases in heart mass (p less than 0.002) and circulating polymorphonuclear leukocytes (p less than 0.03) and reductions in coronary blood flow (p less than 0.0001), circulating lymphocytes (p less than 0.03), and C4 (p less than 0.03). Preformed circulating anti-pig antibodies disappeared in all but one baboon. Hyperacute rejection in this discordant xenograft model that used a nonhuman primate as "recipient" differs in few aspects from that seen in other experimental models. Possible methods of prolonging xenograft survival are discussed.
Similar articles
-
Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon.J Heart Transplant. 1988 May-Jun;7(3):238-46. J Heart Transplant. 1988. PMID: 3290407
-
The role of ABO blood group compatibility in heart transplantation between closely related animal species. An experimental study using the vervet monkey to baboon cardiac xenograft model.J Thorac Cardiovasc Surg. 1989 Mar;97(3):447-55. J Thorac Cardiovasc Surg. 1989. PMID: 2645470
-
Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model.Xenotransplantation. 2005 Mar;12(2):134-41. doi: 10.1111/j.1399-3089.2005.00208.x. Xenotransplantation. 2005. PMID: 15693844
-
Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection.J Surg Res. 1995 Jul;59(1):43-50. doi: 10.1006/jsre.1995.1130. J Surg Res. 1995. PMID: 7630135
-
Feasibility of xeno-transplantation.Surg Clin North Am. 2004 Feb;84(1):289-307. doi: 10.1016/S0039-6109(03)00208-1. Surg Clin North Am. 2004. PMID: 15053194 Review.
Cited by
-
The Long and Winding Road to Clinical Xenotransplantation: A Personal Journey.Eur Surg Res. 2022;63(4):165-172. doi: 10.1159/000525757. Epub 2022 Jun 28. Eur Surg Res. 2022. PMID: 35764060 Free PMC article. Review.
-
Preclinical rationale and current pathways to support the first human clinical trials in cardiac xenotransplantation.Hum Immunol. 2023 Jan;84(1):34-42. doi: 10.1016/j.humimm.2022.07.001. Epub 2022 Jul 15. Hum Immunol. 2023. PMID: 35851182 Free PMC article.
-
How should cardiac xenotransplantation be initiated in Japan?Surg Today. 2024 Aug;54(8):829-838. doi: 10.1007/s00595-024-02861-7. Epub 2024 May 11. Surg Today. 2024. PMID: 38733536 Free PMC article. Review.
-
Single-cell transcriptomic analysis reveals transcriptional and cell subpopulation differences between human and pig immune cells.Genes Genomics. 2024 Mar;46(3):303-322. doi: 10.1007/s13258-023-01456-9. Epub 2023 Nov 18. Genes Genomics. 2024. PMID: 37979077
-
Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans.PLoS One. 2017 Jul 17;12(7):e0180768. doi: 10.1371/journal.pone.0180768. eCollection 2017. PLoS One. 2017. PMID: 28715486 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous